Valley National Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Valley National Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$873	Buy	+11	New	+$828	﹤0.01%	892
2023 Q3	–	Sell	-11	Closed	-$1K	–	1091
2023 Q2	$1K	Hold	11	–	–	﹤0.01%	893
2023 Q1	$0	Hold	11	–	–	﹤0.01%	930
2022 Q4	$0	Hold	11	–	–	﹤0.01%	909
2022 Q3	$1K	Hold	11	–	–	﹤0.01%	844
2022 Q2	$0	Hold	11	–	–	﹤0.01%	933
2022 Q1	$0	Hold	11	–	–	﹤0.01%	949
2021 Q4	$0	Buy	+11	New	+$346	﹤0.01%	940

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Valley National Advisers's IONS Position: Q2 2026 in Review

Valley National Advisers opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 11 shares worth $873. The stake represents ﹤0.01% of the portfolio and ranks #892 among its holdings. This is a return to the name: Valley National Advisers previously reported a position in IONS as recently as Q2 2023.

Valley National Advisers first reported a position in IONS in Q4 2021 and has held it in 8 quarters since. The position peaked at $1K in Q2 2023. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Valley National Advisers held 11 shares of Ionis Pharmaceuticals worth $873 as of Q2 2026.
Ionis Pharmaceuticals was a new Valley National Advisers position in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #892 holding.
Valley National Advisers first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
Valley National Advisers's Ionis Pharmaceuticals position peaked at $1K in Q2 2023.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.